Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Lees

Showing results (821-830 of 1,055) with videos related to

Pageof 106
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|October 8, 2005
Nigral degeneration and striatal dopaminergic dysfunction in idiopathic and Parkin-linked Parkinson's diseaseMichele T M Hu, Christoph Scherfler, Naheed L Khan, et al.
Annals of Neurology|March 25, 2006
Compulsive drug use linked to sensitized ventral striatal dopamine transmissionAndrew H Evans, Nicola Pavese, Andrew D Lawrence, et al.
Archives of Neurology|October 1, 1989
Anal sphincter dysfunction in Parkinson's diseaseS E Mathers, P A Kempster, P J Law, et al.
Brain : a Journal of Neurology|February 26, 2011
Cue-induced striatal dopamine release in Parkinson's disease-associated impulsive-compulsive behavioursSean S O'Sullivan, Kit Wu, Marios Politis, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 10, 2016
Apomorphine: A potential modifier of amyloid deposition in Parkinson's disease?Alison J Yarnall, Tammaryn Lashley, Helen Ling, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 7, 2004
DJ-1 mutations in Parkinson's diseaseD G Healy, P M Abou-Sleiman, E M Valente, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 18, 2004
Tau gene and Parkinson's disease: a case-control study and meta-analysisD G Healy, P M Abou-Sleiman, A J Lees, et al.
Brain : a Journal of Neurology|April 4, 2008
Clinical outcomes of progressive supranuclear palsy and multiple system atrophyS S O'Sullivan, L A Massey, D R Williams, et al.
Psychopharmacology|April 14, 1978
Deprenyl administration in man: a selective monoamine oxidase B inhibitor without the 'cheese effect'J D Elsworth, V Glover, G P Reynolds, et al.
Annals of Neurology|October 1, 1992
Alpha-tocopherol levels in brain are not altered in Parkinson's diseaseD T Dexter, R J Ward, F R Wells, et al.
Pageof 106

Showing results (821-830 of 1,055) with videos related to

Sort By:
Pageof 106
Movement Disorders : Official Journal of the Movement Disorder Society|October 8, 2005
Nigral degeneration and striatal dopaminergic dysfunction in idiopathic and Parkin-linked Parkinson's diseaseMichele T M Hu, Christoph Scherfler, Naheed L Khan, et al.
Annals of Neurology|March 25, 2006
Compulsive drug use linked to sensitized ventral striatal dopamine transmissionAndrew H Evans, Nicola Pavese, Andrew D Lawrence, et al.
Archives of Neurology|October 1, 1989
Anal sphincter dysfunction in Parkinson's diseaseS E Mathers, P A Kempster, P J Law, et al.
Brain : a Journal of Neurology|February 26, 2011
Cue-induced striatal dopamine release in Parkinson's disease-associated impulsive-compulsive behavioursSean S O'Sullivan, Kit Wu, Marios Politis, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 10, 2016
Apomorphine: A potential modifier of amyloid deposition in Parkinson's disease?Alison J Yarnall, Tammaryn Lashley, Helen Ling, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 7, 2004
DJ-1 mutations in Parkinson's diseaseD G Healy, P M Abou-Sleiman, E M Valente, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 18, 2004
Tau gene and Parkinson's disease: a case-control study and meta-analysisD G Healy, P M Abou-Sleiman, A J Lees, et al.
Brain : a Journal of Neurology|April 4, 2008
Clinical outcomes of progressive supranuclear palsy and multiple system atrophyS S O'Sullivan, L A Massey, D R Williams, et al.
Psychopharmacology|April 14, 1978
Deprenyl administration in man: a selective monoamine oxidase B inhibitor without the 'cheese effect'J D Elsworth, V Glover, G P Reynolds, et al.
Annals of Neurology|October 1, 1992
Alpha-tocopherol levels in brain are not altered in Parkinson's diseaseD T Dexter, R J Ward, F R Wells, et al.
Pageof 106